发明名称 Pyrimidine derivatives as CB2 cannabinoid receptor modulators
摘要 The present invention relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
申请公布号 EP1736470(A2) 申请公布日期 2006.12.27
申请号 EP20060121095 申请日期 2003.08.19
申请人 GLAXO GROUP LIMITED 发明人 EATHERTON, ANDREW, JOHN;GIBLIN, GERARD, MARTIN, PAUL;MITCHELL, WILLIAM, LEONARD;NAYLOR, ALAN;RAWLINGS, DEREK, ANTHONY;SLINGSBY, BRIAN, PETER;WHITTINGTON, ANDREW, RICHARD;GREEN, RICHARD, HOWARD
分类号 C07D239/42;A61K31/505;A61K31/506;A61P1/02;A61P1/04;A61P1/06;A61P1/12;A61P1/14;A61P1/16;A61P3/10;A61P5/14;A61P7/00;A61P7/06;A61P7/10;A61P9/00;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P15/00;A61P15/10;A61P17/00;A61P17/02;A61P17/06;A61P17/16;A61P19/00;A61P19/02;A61P19/06;A61P21/00;A61P21/04;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P31/12;A61P31/16;A61P31/18;A61P31/22;A61P35/00;A61P37/00;A61P39/00;A61P41/00;A61P43/00;C07D401/12 主分类号 C07D239/42
代理机构 代理人
主权项
地址